Published in Lancet on February 04, 1967
Anti-lymphocytic antibody--a review. Clin Exp Immunol (1967) 2.75
The selective action of antilymphocyte serum on recirculating lymphocytes: a review of the evidence and alternatives. Clin Exp Immunol (1970) 1.76
The mechanism of action of anti-lymphocyte serum. Studies of antibody eluate. J Exp Med (1969) 1.13
The effect of anti-lymphocyte globulin on human monocytes in vitro. Clin Exp Immunol (1969) 0.98
Modification of the graft-versus-host syndrome by anti-lymphocyte serum treatment of the donor. Clin Exp Immunol (1968) 0.87
Combined immunosuppression for canine renal allograft prolongation: antilymphocyte serum plus prednisolone or azathioprine. Ann Surg (1968) 0.86
Immunosuppressive and graft-rejecting anti--bodies in heterologous anti-lymphocytic serum. J Exp Med (1971) 0.83
Prolonged survival of skin allografts in rats treated with heterologous anti-skin serum. Clin Exp Immunol (1970) 0.80
In vitro monitoring of cadaver kidney donor pretreatment by lymphocyte culture. Clin Exp Immunol (1976) 0.78
Experimental glomerulonephritis in the mouse. II. Effect of antithymocyte globulin. Clin Exp Immunol (1972) 0.75
Comparison of in vitro effects of anti-skin serum with anti lymphocyte serum. Clin Exp Immunol (1973) 0.75
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat Med (2000) 11.90
The case for allowing kidney sales. International Forum for Transplant Ethics. Lancet (1998) 5.25
The case for "presumed consent" in organ donation. International Forum for Transplant Ethics. Lancet (1998) 4.99
Should organs from patients in permanent vegetative state be used for transplantation? International Forum for Transplant Ethics. Lancet (1997) 4.04
Uncertainty in xenotransplantation: individual benefit versus collective risk. Nat Med (1998) 3.54
Five years' experience in renal transplantation with immunosuppressive drugs: survival, function, complications, and the role of lymphocyte depletion by thoracic duct fistula. Ann Surg (1968) 3.34
Immunologic rejection of human cancer transplanted with a renal allograft. N Engl J Med (1968) 2.70
CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med (1995) 2.48
Renal failure in the patient with cirrhosis. The role of active vasoconstriction. Am J Med (1970) 2.43
Metabolism of third complement component (C3) in nephritis. Involvement of the classic and alternate (properdin) pathways for complement activation. N Engl J Med (1972) 2.33
Intrarenal distribution of blood flow in the transplanted dog kidney: effect of denervation and rejection. J Clin Invest (1967) 2.14
Cytomegalovirus infection after renal allotransplantation. JAMA (1967) 2.08
Megaloblastic hematopoiesis in uremia and in patients on long-term hemodialysis. N Engl J Med (1967) 2.06
Cyclosporine: a new immunosuppressive agent for organ transplantation. Ann Intern Med (1984) 2.03
Alteration of the cytotoxic action of sensitized lymphocytes by cholinergic agents and activators of adenylate cyclase. Proc Natl Acad Sci U S A (1972) 2.01
The modulating influence of cyclic nucleotides upon lymphocyte-mediated cytotoxicity. J Exp Med (1973) 1.92
Activation of leukemia viruses by graft-versus-host and mixed lymphocyte reactions in vitro. Proc Natl Acad Sci U S A (1972) 1.85
Subtotal parathyroidectomy in chronic renal failure: a seven-year experience in a dialysis and transplant program. Ann Surg (1971) 1.83
Identity and cytotoxic capacity of cells infiltrating renal allografts. N Engl J Med (1975) 1.82
Urine fibrinogen fragments in human renal allografts. A possible mechanism of renal injury. N Engl J Med (1968) 1.80
Survival of patients undergoing chronic hemodialysis and renal transplantation. N Engl J Med (1973) 1.74
Serum complement component levels in human glomerulonephritis. Ann Intern Med (1971) 1.70
Pathogenesis of a local graft versus host reaction: immunogenicity of circulating host leukocytes. Science (1968) 1.69
Maternal-fetal relation. Absence of an immunologic blocking factor from the serum of women with chronic abortions. N Engl J Med (1976) 1.69
Type I diabetes mellitus in monozygotic twins: chronic progressive beta cell dysfunction. Ann Intern Med (1983) 1.68
Absence of collagen deficiency in familial cerebral aneurysms. J Neurosurg (1989) 1.63
Human renal isografts: a clinical and pathologic analysis. Medicine (Baltimore) (1968) 1.63
Coagulation studies in the hyperacute and other forms of renal-allograft rejection. N Engl J Med (1969) 1.62
Secondary hyperparathyroidism and renal osteodystrophy in chronic renal failure. Analysis of 195 patients, with observations on the effects of chronic dialysis, kidney transplantation and subtotal parathyroidectomy. Medicine (Baltimore) (1969) 1.61
Renal transplantation in the inbred rat. 3. A study of heterologous anti-thymocyte sera. J Exp Med (1967) 1.57
Immunologic dysfunction in patients with classic hemophilia receiving lyophilized factor VIII concentrates and cryoprecipitate. Can Med Assoc J (1983) 1.52
Glomerulonephritis (third of three parts). N Engl J Med (1974) 1.52
Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection. Proc Natl Acad Sci U S A (1996) 1.51
Spontaneous diabetes mellitus syndrome in the rat. I. Association with the major histocompatibility complex. J Exp Med (1981) 1.49
Renal transplantation in the inbred rat. IX. Hematopoietic origin of an immunogenic stimulus of rejection. Transplantation (1969) 1.49
The role of antibodies in the rejection and enhancement of organ allografts.?7318. Adv Immunol (1976) 1.48
Factors contributing to the declining mortality rate in renal transplantation. N Engl J Med (1978) 1.45
Avoidance of cyclosporine in renal transplantation: effects of daclizumab, mycophenolate mofetil, and steroids. J Am Soc Nephrol (2000) 1.45
Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion. J Clin Invest (1978) 1.44
Senescence and the renal vasculature in normal man. Circ Res (1974) 1.43
Alterations in human serum beta-1C-gobulin (C'3) in renal transplantation. Am J Med (1967) 1.42
Intravascular coagulation (IVC) in human renal allograft rejection. Transplant Proc (1969) 1.39
Effects of initial ischemia/reperfusion injury on the transplanted kidney. Transplantation (1997) 1.38
Enzyme replacement therapy by renal allotransplantation in Fabry's disease. N Engl J Med (1972) 1.38
The role of nonclassical Fc receptor-associated, Ag-B antigens (Ia) in rat allograft enhancement. J Exp Med (1976) 1.33
Spontaneous diabetes mellitus syndrome in the rat. II. T lymphopenia and its association with clinical disease and pancreatic lymphocytic infiltration. J Immunol (1983) 1.33
Simplified hippuran clearance. Measurement of renal function in man with simplified hippuran clearances. Nephron (1966) 1.33
Dendritic cell-lymphoid cell aggregation and major histocompatibility antigen expression during rat cardiac allograft rejection. J Exp Med (1986) 1.32
Effect of chronic renal failure and hemodialysis on carbohydrate metabolism. J Clin Invest (1966) 1.30
Improved B cell typing for HLA-DR using nylon wool column enriched B lymphocyte preparations. Tissue Antigens (1979) 1.29
Early-onset pauciarticular juvenile rheumatoid arthritis associated with human leukocyte antigen-DRw5, iritis, and antinuclear antibody. J Clin Invest (1980) 1.29
Two genes required for diabetes in BB rats. Evidence from cyclical intercrosses and backcrosses. J Exp Med (1984) 1.28
Synthetic polypeptide metabolism. 3. Degradation and organ localization of isomeric synthetic polypeptide antigens. J Immunol (1967) 1.28
Hereditary C2 deficiency: diagnosis and HLA gene complex associations. J Immunol (1976) 1.28
Acute oliguric renal failure in man: evidence for preferential renal cortical ischemia. Medicine (Baltimore) (1968) 1.28
Live and learn: patient education delays the need to initiate renal replacement therapy in end-stage renal disease. J Nerv Ment Dis (1993) 1.28
Reduction of immunogenicity of human cadaver renal allografts by donor pretreatment. Transplant Proc (1973) 1.24
The emotional impact of end-stage renal disease: importance of patients' perception of intrusiveness and control. Int J Psychiatry Med (1984) 1.23
Renal transplantation in the inbred rat. I. Morphologic, immunologic, and functional alterations during acute rejection. Transplantation (1967) 1.22
Sauna baths in the treatment of chronic renal failure. Trans Am Soc Artif Intern Organs (1966) 1.22
Mapping of the structural gene for the second component of complement with respect to the human major histocompatibility complex. Am J Hum Genet (1979) 1.22
Editoral: Cardiovascular disease in dialysis patients. N Engl J Med (1974) 1.20
Uremic pericarditis. Clinical features and management. Circulation (1968) 1.20
Human renal allografts. Interpretation of morphologic and immunohistochemical observations. Am J Pathol (1968) 1.19
Expression of interleukin-8 receptors on tumor cells and vascular endothelial cells in human breast cancer tissue. Anticancer Res (1998) 1.19
Effect of mercaptans and other agents on the human complement component beta-1c-globulin. Immunology (1966) 1.17
Liver disease in kidney transplant patients receiving azathioprine. Arch Intern Med (1973) 1.15
Renal transplantation in the inbred rat. II. An immunohistochemical study of acute allograft rejection. Am J Pathol (1968) 1.14
Disappearance of "uremic" itching after subtotal parathyroidectomy. N Engl J Med (1968) 1.13
Effect of sodium balance on intrarenal distribution of blood flow in normal man. J Appl Physiol (1970) 1.13
Cellular components of allograft rejection: identity, specificity, and cytotoxic function of cells infiltrating acutely rejecting allografts. J Immunol (1977) 1.12
Cellular immunity in the mouse. II. Correlation of in vivo and in vitro phenomena. Cell Immunol (1972) 1.12
Hepatitis affecting hemodialysis and transplant patients. Its considerations and consequences. Arch Intern Med (1973) 1.11
Vestibular toxicity of gentamicin. Incidence in patients receiving long-term hemodialysis therapy. Arch Intern Med (1978) 1.10
Rejected human renal allografts: recovery and characteristics of infiltrating cells and antibody. Transplantation (1979) 1.10
Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat. Proc Natl Acad Sci U S A (1992) 1.10
Immune dysfunction in diabetes-prone BB rats. Interleukin 2 production and other mitogen-induced responses are suppressed by activated macrophages. J Exp Med (1984) 1.10
Role of indirect allorecognition in allograft rejection. Int Rev Immunol (1996) 1.10
Cellular immunity in the mouse. I. In vitro lymphocyte reactivity. Cell Immunol (1972) 1.10
Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction. Transplantation (1997) 1.10
Mechanisms of acquired thymic tolerance in experimental autoimmune encephalomyelitis: thymic dendritic-enriched cells induce specific peripheral T cell unresponsiveness in vivo. J Exp Med (1995) 1.10